ThermoGenesis Holdings Inc (THMO)
0.345
-0.04 (-9.26%)
USD |
NASDAQ |
May 20, 16:00
0.35
0.00 (0.00%)
After-Hours: 20:00
ThermoGenesis Holdings Cash from Operations (Quarterly): -0.326M for Dec. 31, 2021
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.326M |
| September 30, 2021 | -1.05M |
| June 30, 2021 | -1.292M |
| March 31, 2021 | -3.952M |
| December 31, 2020 | -2.534M |
| September 30, 2020 | -2.906M |
| June 30, 2020 | -6.412M |
| March 31, 2020 | -2.541M |
| December 31, 2019 | 0.258M |
| September 30, 2019 | -0.607M |
| June 30, 2019 | -0.475M |
| March 31, 2019 | -2.436M |
| December 31, 2018 | 0.448M |
| September 30, 2018 | -1.329M |
| June 30, 2018 | -4.039M |
| March 31, 2018 | -2.063M |
| September 30, 2017 | -1.45M |
| June 30, 2017 | -2.102M |
| March 31, 2017 | -2.543M |
| December 31, 2016 | -0.561M |
| September 30, 2016 | -2.009M |
| June 30, 2016 | -1.276M |
| March 31, 2016 | -3.855M |
| December 31, 2015 | -3.189M |
| September 30, 2015 | -1.305M |
| Date | Value |
|---|---|
| June 30, 2015 | -1.334M |
| March 31, 2015 | -3.446M |
| December 31, 2014 | -2.184M |
| September 30, 2014 | -3.685M |
| June 30, 2014 | -1.74M |
| March 31, 2014 | -1.763M |
| December 31, 2013 | -2.952M |
| September 30, 2013 | -1.381M |
| June 30, 2013 | -0.585M |
| March 31, 2013 | -0.002M |
| December 31, 2012 | -1.718M |
| September 30, 2012 | -0.777M |
| June 30, 2012 | -0.621M |
| March 31, 2012 | -0.165M |
| December 31, 2011 | -1.579M |
| September 30, 2011 | -1.52M |
| June 30, 2011 | -1.107M |
| March 31, 2011 | -0.467M |
| December 31, 2010 | 0.001M |
| September 30, 2010 | -0.519M |
| June 30, 2010 | 0.607M |
| March 31, 2010 | -1.017M |
| December 31, 2009 | -1.763M |
| September 30, 2009 | -2.255M |
| June 30, 2009 | -1.377M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.412M
Minimum
Jun 2020
0.448M
Maximum
Dec 2018
-1.934M
Average
-1.756M
Median
Cash from Operations (Quarterly) Benchmarks
| Savara Inc | -8.425M |
| Catalyst Pharmaceuticals Inc | 8.478M |
| Cyclacel Pharmaceuticals Inc | -6.775M |
| Geron Corp | -33.97M |
| Immunogen Inc | -41.40M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.029M |
| Free Cash Flow | -6.713M |
| Free Cash Flow Per Share (Quarterly) | -0.0298 |
| Free Cash Flow to Equity (Quarterly) | -1.263M |
| Free Cash Flow Yield | -165.0% |